Die Innovative Medicines Initiative 2 (IMI 2) hat ihre 14. Ausschreibungsrunde geöffnet. Sie umfasst die folgenden 4 Themen:

• Topic 1: Targeted immune intervention for the management of non-response and relapse
• Topic 2: Non-invasive clinical molecular imaging of immune cells
• Topic 3: Development of a platform for federated and privacy-preserving machine learning in support of drug discovery
• Topic 4: Centre of excellence – remote decentralised clinical trials